Old and New Drugs for Chronic Lymphocytic Leukemia: Lights and Shadows of Real-World Evidence

Several novel treatments for chronic lymphocytic leukemia (CLL) have been recently approved based on the results of randomized clinical trials. However, real-world evidence (RWE) is also requested before and after drug authorization in order to confirm safety and to provide data for health technolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Marchetti, Monia, Vitale, Candida, Rigolin, Gian Matteo, Vasile, Alessandra, Visentin, Andrea, Scarfò, Lydia, Coscia, Marta, Cuneo, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028394/
https://www.ncbi.nlm.nih.gov/pubmed/35456167
http://dx.doi.org/10.3390/jcm11082076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028394/
https://www.ncbi.nlm.nih.gov/pubmed/35456167
http://dx.doi.org/10.3390/jcm11082076

Ejemplares similares